Literature DB >> 9427202

The effect of topical corticosteroids on refractive outcome and corneal haze after photorefractive keratectomy.

S H Baek1, J H Chang, S Y Choi, W J Kim, J H Lee.   

Abstract

BACKGROUND: The effect of topical corticosteroids after excimer laser photorefractive keratectomy (PRK) remains a matter of some controversy. Refractive effects may be different according to the amount of myopia and timing of instillation.
METHODS: Two groups of patients were studied: Study A consisted of 215 eyes (128 patients) with PRK (mean baseline myopia, -6.53 +/- 2.22 D) that received no corticosteroids (No Corticosteroid Group) unless significant regression or corneal haze appeared (Delayed Corticosteroid Group), and in Study B, we randomly assigned eyes to the Initial Corticosteroid Group (mean baseline myopia, -6.39 +/- 1.84 D) or the No/delayed Corticosteroid Group (mean baseline myopia -5.78 +/- 2.02 D). Clinical results after PRK for low-to-moderate and high myopia were compared.
RESULTS: In the first group, 70.9% (73 eyes) of moderately myopic eyes (mean, -4.56 +/- 1.10 D) belonged to the No Corticosteroid Group that had a mean refraction of -5.39 +/- 1.77 D. Delayed Corticosteroid Group eyes were more myopic (mean, -7.52 +/- 2.10 D), and showed more severe haze than those in the No Corticosteroid Group. In study B, only in high myopes with more than -6.00 D (mean, -7.76 +/- 1.15 D) did refraction and corneal haze outcomes show significant difference between the Initial Corticosteroid Group and the No/delayed Corticosteroid Group.
CONCLUSIONS: The effects of topical corticosteroids after PRK were less in moderate myopes compared to high myopes. Delayed instillation of corticosteroids did not reverse the regression or haze whereas initial instillation showed a beneficial effect on high myopes but not on moderate myopes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9427202     DOI: 10.3928/1081-597X-19971101-11

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  11 in total

1.  Simultaneous photorefractive keratectomy and accelerated collagen cross-linking in high-risk refractive surgery (Tehran protocol): 3-year outcomes.

Authors:  Mehrdad Mohammadpour; Behnaz Farhadi; Reza Mirshahi; Ahmad Masoumi; Masoud Mirghorbani
Journal:  Int Ophthalmol       Date:  2020-06-30       Impact factor: 2.031

2.  Reducing peak corneal haze after photorefractive keratectomy in rabbits: prednisolone acetate 1.00% versus cyclosporine A 0.05%.

Authors:  Chyong Jy Nien; Kevin J Flynn; Melissa Chang; Donald Brown; James V Jester
Journal:  J Cataract Refract Surg       Date:  2011-03-15       Impact factor: 3.351

3.  Optical effects of anti-TGFbeta treatment after photorefractive keratectomy in a cat model.

Authors:  Jens Bühren; Lana Nagy; Jennifer N Swanton; Shawn Kenner; Scott MacRae; Richard P Phipps; Krystel R Huxlin
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

4.  Correlation between the matrix metalloproteinase-9 activity and chondroitin sulfate concentrations in tear fluid after laser in situ keratomileusis.

Authors:  Tetsuya Mutoh; Masaya Nishio; Yukihiro Matsumoto; Kiyomi Arai
Journal:  Clin Ophthalmol       Date:  2010-07-30

5.  Photorefractive keratectomy: measuring the matrix metalloproteinase activity and chondroitin sulfate concentration in tear fluid.

Authors:  Tetsuya Mutoh; Masaya Nishio; Yukihiro Matsumoto; Kiyomi Arai; Makoto Chikuda
Journal:  Clin Ophthalmol       Date:  2010-09-20

6.  Efficacy and safety of a 3-month loteprednol etabonate 0.5% gel taper for routine prophylaxis after photorefractive keratectomy compared to a 3-month prednisolone acetate 1% and fluorometholone 0.1% taper.

Authors:  Mark D Mifflin; Brent S Betts; P Adam Frederick; Jason M Feuerman; Carlton R Fenzl; Majid Moshirfar; Brian Zaugg
Journal:  Clin Ophthalmol       Date:  2017-06-12

7.  A Novel CD147 Inhibitor, SP-8356, Attenuates Pathological Fibrosis in Alkali-Burned Rat Cornea.

Authors:  Chanmin Joung; Hyojin Noh; Jeein Jung; Hwa Young Song; Hwanse Bae; Kisoo Pahk; Won-Ki Kim
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

8.  Use of loteprednol for routine prophylaxis after photorefractive keratectomy.

Authors:  Mark D Mifflin; Lisa L Leishman; Steven M Christiansen; Shameema Sikder; Maylon Hsu; Majid Moshirfar
Journal:  Clin Ophthalmol       Date:  2012-05-01

9.  Topical rosiglitazone is an effective anti-scarring agent in the cornea.

Authors:  Krystel R Huxlin; Holly B Hindman; Kye-Im Jeon; Jens Bühren; Scott MacRae; Margaret DeMagistris; David Ciufo; Patricia J Sime; Richard P Phipps
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

10.  A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgery.

Authors:  Clifford L Salinger; Michael Gordon; Mitchell A Jackson; Theodore Perl; Eric Donnenfeld
Journal:  Clin Ophthalmol       Date:  2015-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.